| abstract |
Ifenprodil has been found to be useful in the treatment of ophthalmic disease states characterized by ocular inflammation, dry eye disorders, increased ocular pressure, pathologic ocular angiogenesis and retinal or sub-retinal edema. Examples of such diseases include age-related macular degeneration, diabetic retinopathy, choroidal neovascular membrane, cystoid macular edema, epi-retinal membrane, macular hole, dry eye, uveitis or glaucoma. |